Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you already take medication for high blood pressure and you're considering Mounjaro (tirzepatide) for weight management, the short answer is that the two can often be used together — but your prescriber needs to know about every medicine you take, because the interaction isn't zero. Mounjaro can lower blood pressure as weight falls, which may require your blood pressure medicines to be adjusted over time. These are prescription-only medicines, and a clinician will assess the full picture before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You're probably not the first person at your GP surgery to ask this. A lot of people who qualify for a weight-loss medicine also have hypertension, they're common companions. The concern is reasonable: adding any new medicine to an existing antihypertensive regimen feels like introducing a variable you can't control.
The reality is more manageable than it might seem. Mounjaro does not directly block or amplify the mechanism of most blood pressure drugs. It doesn't work on the renin-angiotensin system, calcium channels, or beta receptors. What it does do, over weeks and months, is reduce body weight, and weight loss itself reliably lowers blood pressure in people who carry excess weight, something that is well supported by evidence from the SURMOUNT programme, where participants saw meaningful reductions in systolic blood pressure alongside weight loss at the 15mg dose.
The practical implication: if you're on a fixed dose of ramipril, amlodipine, bisoprolol, or any other antihypertensive, that dose was calculated for your body at its current weight. As weight comes down, you may find your blood pressure runs lower than your target range. That's not dangerous in itself, but it does mean your prescriber may want to review and possibly reduce your antihypertensive dose as treatment progresses. It's a good-news problem, but it needs managing.
You can read more about the broader relationship between this medicine and blood pressure on our page covering how Mounjaro affects blood pressure in different clinical situations.
The word 'interaction' covers a wide spectrum. At one end you have dangerous drug combinations that must never be co-prescribed. At the other, you have two treatments whose effects overlap in a way that simply requires monitoring. Mounjaro with antihypertensives sits firmly in the second category for most people.
The main thing to watch for is low blood pressure, known clinically as hypotension. Symptoms can include dizziness when standing up, light-headedness, feeling faint, or unusual fatigue. If you're on a diuretic (a water tablet like furosemide or indapamide) you have a second consideration: the nausea and reduced appetite that some people experience early in Mounjaro treatment can reduce fluid intake, and combining that with a diuretic carries a small risk of dehydration. Staying well hydrated matters, and it's worth discussing with whoever manages your antihypertensive.
For the majority of people, none of this becomes a real problem. But knowing the mechanism means you know what to watch for. Our page on Mounjaro and low blood pressure covers the hypotension picture in more detail, including the symptoms that warrant a call to your GP.
The NHS's patient-level guidance on tirzepatide (available at nhs.uk/medicines/tirzepatide) lists medicines your prescriber should know about before you start, and antihypertensives are among them.
When you complete a consultation at our pharmacy, you list every medicine you take, including over-the-counter ones. A GPhC-registered Independent Prescriber reads your answers (not a decision algorithm) and considers your blood pressure history alongside your BMI, any weight-related conditions, and your overall health profile.
If hypertension is part of that picture, the prescriber may note that your antihypertensive will need monitoring as weight falls. They'll also flag if anything in your combination looks like it requires a GP conversation before Mounjaro starts. In some cases, treating the underlying excess weight is precisely what reduces long-term antihypertensive need, a point that our page on whether Mounjaro can help blood pressure addresses directly.
There's no automatic repeat here: every order is clinically re-reviewed, which is exactly the kind of oversight that matters when you're on two treatments whose effects can compound. If you want to understand what the treatment itself looks like as a whole, our weight-loss treatment overview is a good starting point, or you can look at Mounjaro pricing to understand what a private consultation and treatment includes.
NICE's appraisal of tirzepatide (TA1026) notes that weight-related conditions including high blood pressure are among the comorbidities that may support eligibility, so having hypertension isn't a barrier, it's part of the clinical picture your prescriber will consider carefully.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.